...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What if...?
5
Dec 12, 2015 09:41AM

We are now only at number 2).


Dec 12, 2015 11:20AM
4
Dec 12, 2015 11:43AM
1
Dec 12, 2015 11:59AM
5
Dec 12, 2015 12:38PM
Share
New Message
Please login to post a reply